Search jobs Autoinjectors Market Growing At A CAGR Of 18.1% And To Target $5.73 Billion By 2027
Pune, Maharashtra, India, February 22 2021 (Wiredrelease) Allied Analytics –:Autoinjector is a medical device, which is used to administer a particular dose of drug into the body. These devices are easy to use, are cost effective, and can be used by patients or even by untrained professionals. These devices are preferred over conventional devices as they are efficient, with improved and technologically advanced drug delivery mechanisms. Autoinjectors are used in several applications such as rheumatoid arthritis, anemia, migraine, multiple sclerosis, and other therapies.
The global autoinjectors market is expected to reach $5.73 billion by 2027, registering a CAGR of 18.1% from 2020 to 2027, in terms of value.
Prof. Nikolaos Tzenios PH.D. may have found the golden grail of Health and the optimal diet where eating a fatty diet reduces body weight and improves cardiovascular health markers.
New Immunotherapy Helps Treat Cat Allergy by Angela Mohan on February 8, 2021 at 3:08 PM
High doses of CpG oligonucleotide helps in successfully modulating the immune system s allergic response to the main cat allergen Fel d 1, inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy, as per researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH).
The researchers analysed the molecular mechanisms underlying this tolerance and proposed a pre-clinical allergen-specific immunotherapy approach to improve the treatment and control of this common type of allergy.
The full study results were published recently in the renowned international journal
Novel immunotherapy approach to revert the main hallmarks of cat allergy
Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system s allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy.
The researchers analyzed the molecular mechanisms underlying this tolerance and proposed a pre-clinical allergen-specific immunotherapy approach to improve the treatment and control of this common type of allergy. The full study results were published recently in the renowned international journal
Credit: Copyright: LIH
Researchers from the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) brought forward the potential of high doses of a specific adjuvant molecule, namely CpG oligonucleotide, in successfully modulating the immune system s allergic response to the main cat allergen Fel d 1, thereby inducing a tolerance-promoting reaction and reverting the main hallmarks of cat allergy. The researchers analysed the molecular mechanisms underlying this tolerance and proposed a pre-clinical allergen-specific immunotherapy approach to improve the treatment and control of this common type of allergy. The full study results were published recently in the renowned international journal